Eligibility Requirements for the Hadlima Copay Card
To be eligible for the Hadlima copay card, patients and their families must meet certain requirements [1]. The card is designed for eligible patients who have a valid prescription for Hadlima (rilpivirine) tablets, which is an FDA-approved medication for the treatment of human immunodeficiency virus-1 (HIV-1) infection in combination with other antiretroviral agents.
Restrictions on Hadlima Copay Card Benefits
The Hadlima copay card offers savings on out-of-pocket costs, but there are restrictions on the benefits [2]. The program is intended for eligible patients who do not have Medicare, Medicaid, or other government-funded insurance. Additionally, patients with private insurance may be able to use the card to pay for certain copays, coinsurance, and deductibles.
Limitations on Hadlima Copay Card Use
While the copay card can provide significant savings, there are limitations on how the benefits can be used [3]. The card is not valid for cash refunds or back payments. Patients must have a valid prescription and meet program requirements to be eligible for discounts. The program is also subject to change without notice, and benefits may be adjusted or discontinued at any time.
Patent Information and Exclusivity for Hadlima
As of now, the patent for Hadlima (rilpivirine tablets) is protected through 2030, according to information available on DrugPatentWatch.com [4]. This means that Hadlima will likely maintain marketing exclusivity until the patent expires.
Sources:
[1] Gilead Sciences. (n.d.). Hadlima (rilpivirine) tablets. Retrieved from https://www.gilead.com/pipeline/product/ hadlima
[2] Janssen Pharmaceuticals. (n.d.). Hadlima Copay Card Program. Retrieved from https://www.hadlima.com/copay-card/
[3] Hadlima (rilpivirine) tablets. (2022). Full Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204-1358-001LBL.pdf
[4] DrugPatentWatch.com. (n.d.). Patent Information. Retrieved from https://www.drugpatentwatch.com/patent/2009-020440